Abstract
Focal cortical dysplasias (FCDs) are malformations of cortical development that often result in medically refractory epilepsy, with a greater incidence in the pediatric population. The relationship between the disturbed cortical morphology and epileptogenic activity of FCDs remains unclear. We used the BCNU (carmustine 1-3-bis-chloroethyl-nitrosourea) animal model of cortical dysplasia to evaluate neuronal and laminar alterations and how these result in altered activity of intracortical networks in early life. We corroborated the previously reported morphological anomalies characteristic of the BCNU model, comprising slightly larger and rounder neurons and abnormal cortical lamination. Next, the neuronal activity of live cortical slices was evaluated through large field-of-view calcium imaging as well as the neuronal response to a stimulus that leads to cortical hyperexcitability (pilocarpine). Examination of the joint activity of neuronal calcium time series allowed us to identify intracortical communication patterns and their response to pilocarpine. The baseline power density distribution of neurons in the cortex of BCNU-treated animals was different from that of control animals, with the former showing no modulation after stimulus. Moreover, the intracortical communication pattern differed between the two groups, with cortexes from BCNU-treated animals displaying decreased inter-layer connectivity as compared to control animals. Our results indicate that the altered anatomical organization of the cortex of BCNU-treated rats translates into altered functional networks that respond abnormally to a hyperexcitable stimulus and highlight the role of network dysfunction in the pathophysiology of cortical dysplasia.
Introduction
Focal cortical dysplasias (FCDs) are a type of cortical development malformation that constitutes a frequent cause of refractory epilepsy in the pediatric population and in adults1,2,3,4,5. Clinically, FCDs show great variability in their morphology, extension, and location. Whereas some are large and easily identifiable with conventional imaging methods, others are subtle and difficult to find, which may preclude the possibility of neurosurgical treatment2,6. The mechanisms driving epileptogenesis in FCDs are not fully understood due to the impossibility of performing longitudinal evaluations in patients before the onset of seizures.
Animal models of FCD provide a good opportunity to study the morphological features and pathophysiological mechanisms of epilepsy related to human cortical malformations. The carmustine 1-3-bis-chloroethyl-nitrosourea (BCNU) model has been widely described in rats, inducing in the offspring laminar disarrangement, abnormal cell morphologies, and features similar to those seen in humans with FCD type IIa7,8,9,10,11. While animals with this induced lesion do not present spontaneous seizures, some studies have described an augmented excitability of the malformed cortex12 and enhanced susceptibility of the lesioned animals to trigger seizures8,13,14. In this study, we used the BCNU model to evaluate the physiological repercussions of the morphological alterations seen during early life and determine how these malformations facilitate the generation of abnormal electrical activity. For this, large field-of-view calcium images of live cortical slices allowed us to analyze the spatio-temporal cortical dynamics and how they change after pharmacologically induced stimulation.
Based on the premise that alterations of cellular communication are involved in epilepsy development15, the aim of the present study is to understand the link between cortical morphological alterations and intracortical connectivity before, during, and after an external stimulus is applied. BCNU-treated animals showed cortical dislamination, atypical neuronal morphology, and altered baseline connectivity patterns that abnormally responded to the external stimulus.
Results
M1 micro-structure characteristics
Cerebral cortex microstructure was evaluated at P30 using a neuron-specific marker (anti-NeuN). The spatial profile of neuronal density as a function of cortical depth was qualitatively similar between groups (Fig. 1A). Neuronal morphology is illustrated in Fig. 1A,B. Qualitative evaluation shows that neurons of BCNU-treated animals are slightly larger than those from control animals, which was confirmed by quantitative evaluation of their area (Fig. 1C, top panel), and subtle yet statistically significant increase of roundness of BCNU-treated animals neurons was seen in the superficial portion of the cortex (Zone 1 in Fig. 1C, bottom panel). These changes coincide with previous reports7 and confirm the presence of neuronal alterations in the early stages of their lives. Immunofluorescence of glial fibrillary acidic protein (GFAP) demonstrated qualitatively reduced glial density in the superficial layers and increased branching and widening of astrocytic cell bodies in the deep cortical layers, as compared to controls (Fig. 2).
Evaluation of cortical layers
Two immunofluorescent labels were used to identify neurons that normally reside in specific cortical layers to qualitatively show alterations of cortical layering, namely Necab1 (layer IV) and FoxP2 (layer VI). Evaluation at P30 showed that in controls, Necab1-labeled neurons are spatially homogeneous and their presence is limited to layer IV (Fig. 3A). In contrast, layer IV borders in experimental animals are more difficult to ascertain, with a higher number of labeled neurons in layers II-III. Moreover, the spatial boundaries of Necab1-labeled neurons are less specific, and an increased Necab-1 signal in layers II–III can be detected. FoxP2-labeled neurons were clearly limited to layer VI in control animals. On the other hand, BCNU-treated animals showed a poorly delimited layer VI, and clusters of labeled ectopic neurons could be identified in more superficial layers (Fig. 3B).
Evaluation of calcium time series
Cellular activity in M1 cortex was recorded using a stereo fluorescence microscope (Control 648 ± 184, BCNU 864 ± 149 cells; Fig. 4A). Figure 4B shows the population activity (each line represents one neuron) when stimulated with pilocarpine (red arrow) and an example trace of a calcium signal in one control and one BCNU-treated neuron. Figure 4C represents the time series segmentation used in the analysis of Fig. 6. We evaluated the neuron-specific signal amplitude and reactivity to the hyperexcitable stimulus as a function of depth (Fig. 5) and described the temporal evolution of cell-to-cell communication (Fig. 6).
The overall amplitude of the baseline [Ca2+]i signals was homogeneous throughout the cortical depth in control animals and was mostly concentrated at 10 dB. In contrast, BCNU-treated animals showed a bimodal distribution of baseline signal amplitudes (Fig. 5A,B). Moreover, pilocarpine-induced hyperexcitation triggered high-amplitude signals in control animals (mostly in layers V and VI). BCNU-treated animals, on the other hand, consistently exhibited a bimodal amplitude distribution similar to that seen during baseline conditions and this feature persisted during the evolution of post-stimulus activity (Fig. 5 and Supplementary Fig. 2).
Evaluation of the network configuration in response to hyperexcitation
Using temporal segmentation, the evolution of neuronal communication within M1 before and after the pilocarpine stimulus was evaluated in five non-overlapping temporal windows, each lasting 150 s. BCNU-treated animals showed slightly higher correlation coefficients than control animals during baseline conditions (Fig. 6A). The pilocarpine stimulus induced a bimodal distribution of correlation coefficients in control animals, with both groups showing an increase in the proportion of high correlation coefficients. Only BCNU-treated animals maintained high correlation coefficients following pilocarpine washout (300 s), after which both groups exhibited similar distributions of correlation coefficients (450 s, 600 s).
The relationship between cortical depth and the temporal evolution of connectivity degree was also assessed (Fig. 6B). During basal activity, BCNU-treated animals showed neurons with more connections (i.e., higher node degree, k) than control animals, particularly in superficial cortical layers. Slight changes in node degree were detected immediately after the pilocarpine stimulus, which decreased the number of connections in both groups. At 300 s, the control networks dramatically increased their k-degree and the spread of those connections, representing the effect of the external stimulus. Finally, in the last window, the distribution of the positions and k-degree resembles the initial shape of the window before stimulus. In contrast, BCNU-treated animals showed a progressive decrease in node degree at all depths after the pilocarpine stimulus.
The apparent discrepancy between the increased correlation coefficients in BCNU-treated animals and their reduced node degree led us to evaluate the inter-layer connectivity and its temporal evolution. For that, the statistically significant neuron–neuron interactions of the controls were compared with those of BCNU-treated animals, aggregated across depths (Fig. 6C). Control animals consistently showed a higher node degree between depths than BCNU-treated animals. At baseline, control animals displayed more connections between cortical depths, which was mimicked in the last temporal window. The largest between-group differences in the number of connections across depth positions occurred 300 ms after the pilocarpine stimulus, reflecting a delayed response to hyperexcitation, reverting to the initial conditions in the last window. Finally, three network metrics that evaluate network properties were explored, namely clustering, connectivity efficiency, and assortativity (Fig. 6D). The clustering coefficient was lower in BCNU-treated rats in the last time window. Assortativity showed values that changed over time, with BCNU-treated rats displaying increased assortativity at baseline, followed by reductions after pilocarpine stimulation, although no significant differences were found between groups at this level.
Discussion
We investigated the link between aberrant cortical architecture, neuronal morphology, and intra-cortical communication in a model of abnormal cortical development that resembles human FCD. Evaluation of the primary motor cortex at early life (P30) confirmed previously reported dyslamination and altered neuronal morphologies (i.e., slightly larger and rounder neurons; Fig. 1) and morphological signs of glial activation (Fig. 2), all relevant characteristics of BCNU-treated animals7,16. Moreover, cortical layer-specific antibodies not only revealed dyslamination but also the presence of neuronal clusters (Fig. 3). Analysis of neuronal population dynamics through calcium imaging demonstrated that the micro-anatomical alterations were accompanied by abnormal neuronal activity (Fig. 5) during basal activity and pilocarpine, and also during post-stimulus time evolution (Supplementary Fig. 2) and intra-cortical network interactions and dynamics (Fig. 6).
Despite having histopathological hallmarks that resemble human FCD type IIa, BCNU-treated animals do not develop spontaneous seizures7,8,10,11,12,16. However, they exhibit epileptiform activity in the hippocampus and neocortex late in brain development8, as well as evoked epileptiform discharges after (Gamma-aminobutiric-acid) GABAA receptor blockade12. The lack of spontaneous seizures in the absence of a precipitating agent is common in other rodent models of cortical malformations6,17,18,19,20.
In line with previous findings, none of our animals triggered spontaneous seizures. However, they displayed altered cortical activity, as evidenced by [Ca2+]i imaging. At the individual level, cells in the control cortexes showed a different amplitude distribution at baseline, with a subset of neurons modifying their amplitude after the pilocarpine stimulus. Furthermore, cells recorded from BCNU-treated animals showed a bimodal distribution during baseline activity and also during the external stimulus. This could be explained by aberrant intracortical circuits due to cortical malformations, but it is also possible that BCNU directly altered the Ca2+ metabolism of neurons (see below). Nonetheless, the presence of altered activity (observed here via calcium activity and in previous reports via direct electrophysiological recordings8 without seizures) is reminiscent of the human condition, in which this congenital cortical injury often does not translate into clinical seizures until years after birth. Continued plasticity during postnatal cortical development likely unmasks altered neuronal activity and allows the propagation of epileptogenic discharges21.
Cortical dysplasias arise from altered processes related to cell migration and proliferation22,23. These alterations could result in abnormal patterns of intracortical communication and contribute to the development of epilepsy. The BCNU animal model has an important impact on one of these processes since induction occurs during the onset of cell migration. To approach the ways in which cellular functionality and communication could be altered under these conditions, in this work we employed large field-of-view calcium imaging, which helped us analyze the population dynamics and infer the connectivity of the entire depth of a specific neocortical region. Our results indicate that abnormal morphology and laminar organization entail repercussions for intra-cortical communication (Fig. 6C) in addition to alterations in individual neurons. This is evident in the anomalous connectivity patterns between neurons in BCNU-treated animals, which present differences in the numbers and strength of connections as well as the spread of connectivity (Fig. 6A,B). Such differences were present even before the stimulus and, moreover, were differentially modulated between groups by pilocarpine, with different patterns of return to baseline activity. The largest between-group differences were observed in the 300-s post-pilocarpine stimulation window, a result already expected from the knowledge that pilocarpine acts by a metabotropic response that involves binding to M1 muscarinic receptors, coupled to Gα proteins and that leads to a non-immediate response such as electrical stimulation and transmission; with control animals showing a transient increase in widespread connectivity (i.e., increased k-degree; Fig. 6B), whereas the number of connections did not increase in BCNU-treated animals. However, the connections seen in control animals during this timeframe, despite being increased in number, were less tightly coupled than those seen in BCNU-treated animals (i.e., lower correlation coefficients in control animals; Fig. 6A). While pilocarpine induces a spread of excitation throughout the cortex in control animals, the already altered intracortical circuits of BCNU-treated animals (as seen in the baseline condition) modulate the response to the pharmacological stimulation and do not permit the structure of intracortical connectivity to return to its original state. Global network metrics, however, did not differ between groups (Fig. 6D), likely due to the large size of the networks and the variability among specimens.
Throughout this work, we analyzed the time course of the [Ca2+]i activity for each neuron, based on the assumption that alterations in neuronal Ca2+ homeostasis contribute to the pathogenesis of epilepsy because Ca2+ is both a messenger and signal transducer24,25,26,27. There is evidence that alteration of the intra-neuronal concentration of this ion during an external stimulus disrupts cell activity and impacts the activation of other membrane receptors24. These factors likely influence the temporal evolution of [Ca2+]i signals and argue in favor of the analysis of time series rather than their deconvolution to derive neuronal events. In addition, direct between-group comparison of the [Ca2+]i time series before, during, and after the pilocarpine stimulus allowed us to investigate the presence of pre-existing signaling alterations in BCNU-treated animals, as well as their response to a stimulus that led to hyperexcitability and the (lack of) return to baseline activity.
Our results are possibly related to BCNU-induced abnormal development, which can go beyond the organization of the cortex and alter several cellular pathways. Of note is the mTOR pathway, involved in the activation of calcium ATPases, like sarcoendoplasmatic Ca2+ ATPase (SERCA), plasma membrane Ca2+ ATPase and inositol 1,4,5-trisphosphate receptor type I, in neurons28,29,30. Recent advancements in the study of FCDs have confirmed the involvement of the mTOR pathway, which regulates physiological cellular functions such as cell growth, proliferation, ion channel expression, and synaptic and circuit plasticity31,32,33,34,35. Indeed, in utero electroporation for the introduction of the mutant MTOR transcript induces the generation of FCD and spontaneous seizures36, and the associated morphological alterations vary as a function of mTOR hyperactivation37. Notably, disruption of cortical layering is not a requisite for seizure generation, whereas the presence of dysmorphic neurons is35.
The BCNU animal model provides an analog of the microarchitectural disarrangement of human FCDs, but it is insufficient for a complete description of the epileptogenesis of such lesions. Nevertheless, we confirmed that altered microscopic anatomy of the cortex translates into altered neuronal activity and response to a pharmacological manipulation that leads to hyperexcitability in the primary motor cortex. Further work should evaluate other neocortical regions and the hippocampus, where previous reports have demonstrated anatomical alterations7,9,11,16. While the sample size investigated here is relatively small, the morphological features identified in M1 at P30 are in line with previous reports7,16. Moreover, recent work from our group in a larger n of BCNU-treated animals showed similar alterations of neuronal layering in the cortex, as well as alterations of myeloarchitecture38. A limitation of our work is the lack of characterization of the cells in our calcium imaging recordings. The identification of their excitatory or inhibitory nature, expression of markers of dysplastic neurons, as well as the changes in distribution and density of M1 in the cortex evaluated and morphological characteristics, and morphological characteristics, simultaneous with their activity over time, would enrich network analyses. This, however, represented a major technical challenge that we were not able to address.
In this study, we focused only on pilocarpine as a mechanism to perturb cortical activity, although there are other approaches to simulating seizure activity and hyperexcitability to understand epileptogenesis. Alteration of neuronal dynamics in live cortical slices can only be achieved with high concentrations of pilocarpine39, such as the one we used, thereby limiting the generalizability of our findings. Other pharmacological interventions should be explored to validate our results40. Recent animal models that induce FCD through in utero electroporation41, which produce dysmorphic neurons that can elicit and sustain seizure-like activity, should provide further insight into the generation and spread of abnormal activity within the cortex and allow for a better understanding of the anatomy and function of intracortical networks.
Conclusions
Our work shows that in the BCNU animal model of cortical dysplasia, subtle morphological alterations at early life are linked to abnormal baseline neuronal activity and intracortical communication that, in turn, translate into aberrant responses to an external stimulus that causes hyperexcitation. Assessment of intracortical connectivity highlights the role of network dysfunction in the pathophysiology of cortical dysplasia. This contribution may guide the refinement of computational models of neocortical epileptogenesis and further improve our understanding of this common cause of focal epilepsy.
Methods
Animals
Protocols followed in this study were approved by the ethics committee of the Institute of Neurobiology, UNAM (Protocol #111-A) and carried out in accordance with federal regulatory laws for animal experimentation (NOM-062-ZOO-1999). All methods were compliant with the ARRIVE guidelines and regulations. Pregnant Sprague–Dawley rats were intraperitoneally injected with BCNU, n = 5 (Sigma-Aldrich; 20 mg/kg diluted in 5% sucrose) on gestational day E15. A single administration of this alkylating agent during the cortical development of the embryo results in cortical malformations7. Control animals (n = 3) were injected with corresponding volumes of saline solution on the same gestational day. Litters resulting from rats injected with BCNU had similar mortality rates as controls, and the pups appeared and behaved normally, except for their slightly smaller size and lower body weight. Pups remained with their dam until weaning day (P21). All animals were housed in a room with a 12-h light/dark cycle and had free access to food and water. A total of 19 rats (Control: 6 males, 2 females; BCNU: 8 males, 3 females) were evaluated at P30. There were two forms of evaluation, each rat serving in only one, with sample sizes indicated in each corresponding section.
Immunostaining
Rats (Control = 3, BCNU = 3) were perfused intracardially with 4% paraformaldehyde (PFA; Sigma-Aldrich). Then, the brains were removed and placed in a fresh 4% solution overnight. Next, they were transferred to a 20% sucrose (w/v) solution in PBS 1x (w/v) for 24 h, followed by a 30% sucrose (w/v) solution with the same duration. Tissues were frozen using absolute ethanol and liquid nitrogen and stored at − 20 °C until sectioning. Coronal slices (20 μm thick) were obtained with a cryostat microtome (Leica) near Bregma (9.20 mm). Sections were preserved in PBS 1x (w/v), then washed (5 × 10 min) with PBS 1x + Tween 20, 0.3% (w/v) (Sigma-Aldrich). Blocking was performed with PBS 1x, Triton X-100, and 0.3% (v/v) BSA 2% (blocking solution) for 45 min at room temperature, then incubated overnight at 4 °C with primary layer-specific antibodies (NBP1-86671, Foxp2; polyclonal 1:2000, NBP1-84004, Necab; polyclonal 1:500, Novus Biologicals) and ab104224 NeuN 1:350 (Abcam) and G3893, GFAP 1:350 (Sigma-Aldrich). Fluorescently tagged secondary antibodies (Molecular Probes, AlexaFluor, goat anti-rabbit -488, -555, and goat anti-mouse -647, diluted at 1:500 in blocking solution) were incubated for 4 h at 4 °C and cover-slipped with microscope cover glass. Double or triple immunofluorescence was assessed with a laser confocal microscope (Zeiss LSM 780 DUO).
Calcium imaging
Rats (Control = 5, BCNU = 8) were deeply anesthetized with isoflurane and then decapitated. The brain was quickly removed from the skull and immediately placed into an ice-cold oxygenated (95% O2; 5% CO2) solution (in mM: 2.5 KCl, 28 NaHCO3, 1.25 NaHPO4, 7 MgCl2, 0.5 CaCl2, 235 sucrose). Using a vibratome, coronal slices (230 μm) of the medial motor cortex of each brain were obtained and kept at room temperature, continuously bathed with artificial cerebrospinal fluid (ACSF, pH 7.4) gassed with 5% CO2 and 95% O2 for 20 min. Then, the slices were incubated with the cell-permeable fluorescent Ca2+ indicator Fluo-4 AM (Molecular Probes/Invitrogen) at a final concentration of 14 μM (prepared from a 2 mM stock solution in dimethyl sulfoxide with 0.6% Pluronic F-127; Sigma-Aldrich). Dye loading proceeded in the incubator chamber at 37 °C and normal atmospheric conditions (95% O2; 5% CO2) for 1 h. Then, each slice was placed in the bottom of a Plexiglass chamber attached to the stage of the microscope and continuously perfused (2 ml/min) with gassed physiological solution ACSF 1x (in mM: 126 NaCl, 5 KCl, 2 CaCl, 2 MgSO4, 26 NaHCO3, 1.25 NaH2PO4, 10 glucose) at room temperature. We recorded the calcium activity with a stereoscopic fluorescence microscope (Leica M205 FCA) with a 2.0 × PlanApo objective (max. aperture 0.35), coupled to a CCD camera sampling at 3.3 Hz.
Time series were recorded at basal activity and during external stimulation in one slice per animal. We selected the 300 μM pilocarpine concentration based on a previously reported extracellular activity dose–response curve39. Each slice was recorded following the next sequence: (1) basal activity with ACSF perfusion (3 min); (2) a pilocarpine stimulus (30 s) followed by 13 min of ACSF perfusion; (3) a 15 min pause with ACSF solution without light stimulation; and (4) a KCl stimulus (30 s) and the rest of ACSF perfusion to assess the total sample of cells that had activity during the recordings. Only neurons showing activity during all stages of recording and responsive to the KCl stimulus were analyzed.
Data analysis
Morphological evaluation
Using the anti-NeuN immunofluorescence label, we manually delineated the perimeter of each cell within a fixed-width region (500 μm) in M1 and stored it as a region of interest (ROI) with FIJI software41,42. We measured the depth of the center of mass of each ROI, which was normalized with respect to the thickness of the cortex for each specimen. To assess morphological changes commonly observed in dysplastic neurons, the area and roundness of each cell was obtained by fitting an ellipse to each ROI using FIJI42. Between-group differences for both shape descriptors were assessed using Student’s t-test on the pooled data comprising all neurons from all specimens, assessed at two different cortical depths (layers II–III and layer V, zones I and II).
Calcium activity and signal analysis
Neurons were manually selected by drawing ROIs, and the average pixel intensity (i.e., fluorescence) was extracted at each frame using FIJI41,42. Fluorescence values were normalized as ΔF/Fmin in each ROI, then a third-order Bessel low-pass filter was applied by Signals Scipy43 and corrected for bleaching of the signal through a linear regression.
The full waveform of the calcium time series was evaluated; for each, the frequency and power spectra were obtained using Welch’s method, and those values were correlated with the depth of each identified neuron, which was calculated using their corresponding ROI coordinates and normalized to the cortical thickness (0–1 values, where zero corresponds to the interface with white matter and one corresponds to the pial surface). In this evaluation, we separated the calcium time series into two major periods based on the time of stimulation. One was related to baseline and the other to the response after stimulation (i.e., after the pilocarpine stimulus). We assessed the statistical significance of each activity (basal and pilocarpine) between groups using Student's t-test. The post-pilocarpine period was subdivided into 150 s windows to show the evolution of changes (see Supplementary Fig. 2).
Time series selection, connectivity, and network evolution
Calcium time series were selected if their activity during the 30 s pilocarpine stimulus was considerably higher than baseline activity (two standard deviations from the maximum power value). Spectral analyses were conducted for each neuron’s time series. Correlations (Spearman’s ⍴) were used to infer cell-to-cell connectivity, and the statistical significance of these correlations was assessed by comparing them to an empirically created null distribution of correlations between synthetic signals (n = 1000 for each signal) constructed by the amplitude and phase values sampled from the real data; correlations outside two standard deviations from the null distribution mean were selected. The false discovery rate44 was used to further refine the resulting adjacency matrices by controlling for multiple comparisons. A connection was defined as a significant pairwise correlation after such correction, and the node degree (k) corresponds to the number of such connections.
The evolution of the resulting network was evaluated over five discrete time intervals: 0–150 s (before), 151–300 s (window 1), 301–450 s (window 2), 451–600 s (window 3), and 600–750 s (window 4). The first interval represents the time period without an external stimulus; the second one corresponds to the moment reflecting the acute effects of pilocarpine; and the last three intervals represent the rest of the time series. From these time-dependent adjacency matrices, we derived network metrics, namely efficiency of communication, cluster coefficient, and assortativity values, using NetworkX45 and R version 4.2.246. Linear mixed effects, as implemented in lme447, were used to evaluate the relationship between network metrics, the experimental group, and time. Group and time were entered into the model as fixed effects, while subjects were entered as random effects. Statistical significance was assessed with p values obtained by likelihood ratio tests of the full model with the effect in question versus the model without the effect in question.
Node degree evaluation and principal interactions
A depth-dependent analysis of the number of connections (node degree) per neuron was performed. For each time window, the normalized cortical thickness was divided into 0.1 steps, for which the average node degree was calculated relative to basal activity. Statistically significant differences were assessed using Student’s t-tests, and effect sizes were estimated with Cohen’s d47,48.
Data availability
Calcium time series for all experimental animals and conditions are available at https://doi.org/10.5281/zenodo.7675887.
References
Blumcke, I. et al. Neocortical development and epilepsy: Insights from focal cortical dysplasia and brain tumours. Lancet Neurol. 20, 943–955 (2021).
Najm, I. M., Sarnat, H. B. & Blümcke, I. Review: The international consensus classification of Focal Cortical Dysplasia—A critical update 2018. Neuropathol. Appl. Neurobiol. 44, 18–31 (2018).
Kabat, J. & Król, P. Focal cortical dysplasia—review. Pol. J. Radiol. 77, 35–43 (2012).
Sisodiya, S. M., Fauser, S., Cross, J. H. & Thom, M. Focal cortical dysplasia type II: Biological features and clinical perspectives. Lancet Neurol. 8, 830–843 (2009).
Krsek, P. et al. Different features of histopathological subtypes of pediatric focal cortical dysplasia. Ann. Neurol. 63, 758–769 (2008).
Harrington, E. P., Möddel, G., Najm, I. M. & Baraban, S. C. Altered glutamate receptor—Transporter expression and spontaneous seizures in rats exposed to methylazoxymethanol in utero. Epilepsia 48, 158–168 (2007).
Moroni, R. F. et al. Altered spatial distribution of PV-cortical cells and dysmorphic neurons in the somatosensory cortex of BCNU-treated rat model of cortical dysplasia. Epilepsia 49, 872–887 (2008).
Pennacchio, P. et al. Increased pCREB expression and the spontaneous epileptiform activity in a BCNU-treated rat model of cortical dysplasia. Epilepsia 56, 1343–1354 (2015).
Moroni, R. F. et al. In vivo detection of cortical abnormalities in BCNU-treated rats, model of cortical dysplasia, using manganese-enhanced magnetic resonance imaging. Neuroscience 192, 564–571 (2011).
Inverardi, F. et al. Cytoarchitectural, behavioural and neurophysiological dysfunctions in the BCNU-treated rat model of cortical dysplasia. Eur. J. Neurosci. 37, 150–162 (2013).
Moroni, R. F. et al. Development of cortical malformations in BCNU-treated rat, model of cortical dysplasia. Neuroscience 175, 380–393 (2011).
Benardete, E. A. & Kriegstein, A. R. Increased excitability and decreased sensitivity to GABA in an animal model of dysplastic cortex. Epilepsia 43, 970–982 (2002).
Setkowicz, Z., Kłak, K. & Janeczko, K. Long-term changes in postnatal susceptibility to pilocarpine-induced seizures in rats exposed to gamma radiation at different stages of prenatal development. Epilepsia 44, 1267–1273 (2003).
Colciaghi, F. et al. Status epilepticus-induced pathologic plasticity in a rat model of focal cortical dysplasia. Brain 134, 2828–2843 (2011).
Rakhade, S. N. & Jensen, F. E. Epileptogenesis in the immature brain: Emerging mechanisms. Nat. Rev. Neurol. 5, 380–391 (2009).
Moroni, R. F. et al. Expression of layer-specific markers in the adult neocortex of BCNU-Treated rat, a model of cortical dysplasia. Neuroscience 159, 682–691 (2009).
Sancini, G. et al. Dysplastic neocortex and subcortical heterotopias in methylazoxymethanol-treated rats: An intracellular study of identified pyramidal neurones. Neurosci. Lett. 246, 181–185 (1998).
Colacitti, C. et al. Prenatal methylazoxymethanol treatment in rats produces brain abnormalities with morphological similarities to human development brain dysgeneses. J. Neuropathol. Exp. Neurol. 58, 92–106 (1999).
Penschuck, S., Flagstad, P., Didriksen, M., Leist, M. & Michael-Titus, A. T. Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia. Eur. J. Neurosci. 23, 279–284 (2006).
Tsai, V. et al. Fetal brain mTOR signaling activation in tuberous sclerosis complex. Cereb. Cortex 24, 315–327 (2014).
Abdijadid, S., Mathern, G. W., Levine, M. S. & Cepeda, C. Basic mechanisms of epileptogenesis in pediatric cortical dysplasia. CNS Neurosci. Ther. 21, 92–103 (2015).
Buchsbaum, I. Y. & Cappello, S. Neuronal migration in the CNS during development and disease: Insights from in vivo and in vitro models. Development 146, dev163766 (2019).
Yamaguchi, T. et al. N,N′-Bis(2-chloroethyl)-N-nitrosourea (BCNU)-induced apoptosis of neural progenitor cells in the developing fetal rat brain. J. Toxicol. Pathol. 23, 25–30 (2010).
DeLorenzo, R. J., Pal, S. & Sombati, S. Prolonged activation of the N-methyl-d-aspartate receptor–Ca2+ transduction pathway causes spontaneous recurrent epileptiform discharges in hippocampal neurons in culture. Proc. Natl. Acad. Sci. 95, 14482–14487 (1998).
Sun, D. A., Sombati, S., Blair, R. E. & DeLorenzo, R. J. Long-lasting alterations in neuronal calcium homeostasis in an in vitro model of stroke-induced epilepsy. Cell Calcium 35, 155–163 (2004).
Steinlein, O. K. Calcium signaling and epilepsy. Cell Tissue Res. 357, 385–393 (2014).
Pal, S., Sun, D., Limbrick, D., Rafiq, A. & DeLorenzo, R. J. Epileptogenesis induces long-term alterations in intracellular calcium release and sequestration mechanisms in the hippocampal neuronal culture model of epilepsy. Cell Calcium 30, 285–296 (2001).
Genazzani, A. A., Carafoli, E. & Guerini, D. Calcineurin controls inositol 1,4,5-trisphosphate type 1 receptor expression in neurons. Proc. Natl. Acad. Sci. 96, 5797–5801 (1999).
Guerini, D., Wang, X., Li, L., Genazzani, A. & Carafoli, E. Calcineurin controls the expression of isoform 4CII of the plasma membrane Ca2+ pump in neurons. J. Biol. Chem. 275, 3706–3712 (2000).
Bilmen, J. G., Wootton, L. L. & Michelangeli, F. The inhibition of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase by macrocyclic lactones and cyclosporin A. Biochem. J. 366, 255–263 (2002).
Baybis, M. et al. mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann. Neurol. 56, 478–487 (2004).
Miyata, H., Chiang, A. C. Y. & Vinters, H. V. Insulin signaling pathways in cortical dysplasia and TSC-tubers: Tissue microarray analysis. Ann. Neurol. 56, 510–519 (2004).
Crino, P. B. Focal brain malformations: Seizures, signaling, sequencing. Epilepsia 50, 3–8 (2009).
Wong, M. Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformations. Exp. Neurol. 244, 22–26 (2013).
Lee, W. S. et al. Cortical dysplasia and the mTOR pathway: How the study of human brain tissue has led to insights into epileptogenesis. Int. J. Mol. Sci. 23, 1344 (2022).
Lim, J. S. et al. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy. Nat. Med. 21, 395–400 (2015).
Nguyen, L. H., Mahadeo, T. & Bordey, A. mTOR Hyperactivity levels influence the severity of epilepsy and associated neuropathology in an experimental model of tuberous sclerosis complex and focal cortical dysplasia. J. Neurosci. 39, 2762–2773 (2019).
Villaseñor, P. J. et al. Multi-tensor diffusion abnormalities of gray matter in an animal model of cortical dysplasia. Front. Neurol. 14, 1124282 (2023).
Marchi, N. et al. In vivo and in vitro effects of pilocarpine: Relevance to ictogenesis. Epilepsia 48, 1934–1946 (2007).
Raol, Y. H. & Brooks-Kayal, A. R. Chapter 1—experimental models of seizures and epilepsies. In Progress in Molecular Biology and Translational Science Vol. 105 (ed. Conn, P. M.) 57–82 (Academic Press, 2012).
Hsieh, L. S. et al. Convulsive seizures from experimental focal cortical dysplasia occur independently of cell misplacement. Nat. Commun. 7, 11753 (2016).
Schindelin, J. et al. Fiji: An open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
Virtanen, P. et al. SciPy 1.0: Fundamental algorithms for scientific computing in Python. Nat. Methods 17, 261–272 (2020).
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Methodol. 57, 289–300 (1995).
Hagberg, A., Swart, P. & S Chult, D. Exploring network structure, dynamics, and function using networkx. https://www.osti.gov/biblio/960616 (2008).
R Core, T. R: A language and environment for statisticalcomputing. https://www.R-project.org/ (2021).
Winter, B. Linear models and linear mixed effects models in R with linguistic applications. Preprint at http://arxiv.org/abs/1308.5499 (2013).
Cohen, J. Statistical Power Analysis for the Behavioral Sciences | Jacob Cohen|https://www.taylorfrancis.com/books/mono/, https://doi.org/10.4324/9780203771587/statistical-power-analysis-behavioral-sciences-jacob-cohen.
Acknowledgements
We thank Mirelta Regalado for her technical support during tissue preparation, Nydia Hernandez Ríos for her support in acquisition of microscopy images, and Ericka de los Ríos for histology and immunofluorescence orientation. Drs. Gerardo Rojas-Piloni and José Bargas provided invaluable ideas throughout this project. We also thank Jessica Gonzalez-Norris for proofreading and editing our manuscript. Ana Aquiles is a doctoral student from Programa de Doctorado en Ciencias Biomédicas, Universidad Nacional Autónoma de México (UNAM).
Funding
This work was supported by UNAM-DGAPA PAPIIT (IN204720 LC, IA200621 HLM) and Conacyt (FC1782 and C-497/2023). Ana Aquiles received scholarship support through CONACYT 756903.
Author information
Authors and Affiliations
Contributions
A.A. and L.C. wrote the main manuscript text, A.A. and T.F. performed the experiments, A.A. analyzed the data, A.A. and H.L-M. implemented the animal model. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Aquiles, A., Fiordelisio, T., Luna-Munguia, H. et al. Altered functional connectivity and network excitability in a model of cortical dysplasia. Sci Rep 13, 12335 (2023). https://doi.org/10.1038/s41598-023-38717-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-38717-2
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.